Sean Stalfort serves as Executive at Verrica Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Sean Stalfort has executed 7 insider transactions totaling $490.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 14, 2020 involved purchasing 15,700 shares valued at $100.2K.
Sean Stalfort currently holds 462,110 shares of Verrica Pharmaceuticals Inc. (VRCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean Stalfort has been a net buyer of VRCA stock. They have purchased $490.9K and sold $0 worth of shares.
Sean Stalfort's most recent insider trade was on Aug 14, 2020, when they purchased 15,700 shares at $6.38 per share.
Get notified when new Form 4 filings are submitted
| $6.45 |
| Discretionary |
| Nov 12, 2019 | DOVA | $17.5M | Tender | 635,665 | $27.50 | Discretionary |
| Jan 7, 2019 | VRCA | $83.3K | Purchase | 8,021 | $10.38 | Discretionary |
| Jan 7, 2019 | VRCA | $13.1K | Purchase | 1,200 | $10.94 | Discretionary |
| Dec 20, 2018 | DOVA | $194.1K | Purchase | 31,000 | $6.26 | Discretionary |
| Jun 19, 2018 | VRCA | $0 | Conversion | 394,295 | $N/A | Discretionary |